vs
Encompass Health Corp（EHC）とPetco Health & Wellness Company, Inc.（WOOF）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.5B、Petco Health & Wellness Company, Inc.の約1.1倍）。Encompass Health Corpの純利益率が高く（9.5% vs 0.6%、差は8.8%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs -3.1%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $60.6M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs -6.5%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
Petcoヘルスアンドウェルネス社はアメリカの大手ペット小売業者で、本社機能をサンディエゴとサンアントニオに置いています。ペットフード、ペット用品、各種ペット関連サービスを提供するほか、一部の小型生体ペットの販売も手がけています。
EHC vs WOOF — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $1.5B |
| 純利益 | $146.1M | $9.3M |
| 粗利率 | — | 38.9% |
| 営業利益率 | 16.7% | 2.0% |
| 純利益率 | 9.5% | 0.6% |
| 売上前年比 | 9.9% | -3.1% |
| 純利益前年比 | 20.8% | 156.0% |
| EPS（希薄化後） | $1.43 | $0.03 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | $1.4B | $1.5B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | $1.3B | $1.7B |
| Q4 25 | $146.1M | $9.3M | ||
| Q3 25 | $126.5M | $14.0M | ||
| Q2 25 | $142.1M | $-11.7M | ||
| Q1 25 | $151.5M | $-13.8M | ||
| Q4 24 | $120.9M | $-16.7M | ||
| Q3 24 | $108.2M | $-24.8M | ||
| Q2 24 | $114.1M | $-46.5M | ||
| Q1 24 | $112.5M | $-22.6M |
| Q4 25 | — | 38.9% | ||
| Q3 25 | — | 39.3% | ||
| Q2 25 | — | 38.2% | ||
| Q1 25 | — | 38.0% | ||
| Q4 24 | — | 38.1% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | 37.8% | ||
| Q1 24 | — | 36.2% |
| Q4 25 | 16.7% | 2.0% | ||
| Q3 25 | 14.9% | 2.9% | ||
| Q2 25 | 16.2% | 1.1% | ||
| Q1 25 | 16.4% | 1.1% | ||
| Q4 24 | 14.3% | 0.3% | ||
| Q3 24 | 13.6% | 0.2% | ||
| Q2 24 | 14.3% | -1.1% | ||
| Q1 24 | 13.6% | 0.0% |
| Q4 25 | 9.5% | 0.6% | ||
| Q3 25 | 8.6% | 0.9% | ||
| Q2 25 | 9.7% | -0.8% | ||
| Q1 25 | 10.4% | -0.9% | ||
| Q4 24 | 8.6% | -1.1% | ||
| Q3 24 | 8.0% | -1.6% | ||
| Q2 24 | 8.8% | -3.0% | ||
| Q1 24 | 8.5% | -1.3% |
| Q4 25 | $1.43 | $0.03 | ||
| Q3 25 | $1.24 | $0.05 | ||
| Q2 25 | $1.39 | $-0.04 | ||
| Q1 25 | $1.48 | $-0.05 | ||
| Q4 24 | $1.18 | $-0.06 | ||
| Q3 24 | $1.06 | $-0.09 | ||
| Q2 24 | $1.12 | $-0.17 | ||
| Q1 24 | $1.10 | $-0.09 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $237.4M |
| 総負債低いほど良い | $2.4B | — |
| 株主資本純資産 | $2.4B | $1.2B |
| 総資産 | $7.1B | $5.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $237.4M | ||
| Q3 25 | $48.7M | $188.7M | ||
| Q2 25 | $99.1M | $133.3M | ||
| Q1 25 | $95.8M | $165.8M | ||
| Q4 24 | $85.4M | $116.7M | ||
| Q3 24 | $147.8M | $127.6M | ||
| Q2 24 | $154.4M | $89.7M | ||
| Q1 24 | $134.4M | $125.4M |
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $2.4B | $1.2B | ||
| Q3 25 | $2.4B | $1.1B | ||
| Q2 25 | $2.3B | $1.1B | ||
| Q1 25 | $2.2B | $1.1B | ||
| Q4 24 | $2.1B | $1.1B | ||
| Q3 24 | $2.0B | $1.1B | ||
| Q2 24 | $1.8B | $1.2B | ||
| Q1 24 | $1.7B | $1.2B |
| Q4 25 | $7.1B | $5.2B | ||
| Q3 25 | $6.9B | $5.2B | ||
| Q2 25 | $6.8B | $5.1B | ||
| Q1 25 | $6.6B | $5.2B | ||
| Q4 24 | $6.5B | $5.2B | ||
| Q3 24 | $6.5B | $5.3B | ||
| Q2 24 | $6.4B | $5.3B | ||
| Q1 24 | $6.2B | $5.4B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $90.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $60.6M |
| FCFマージンFCF / 売上 | 7.6% | 4.1% |
| 設備投資強度設備投資 / 売上 | 14.8% | 2.0% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 9.66× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $129.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $90.1M | ||
| Q3 25 | $270.8M | $85.9M | ||
| Q2 25 | $270.2M | $-15.5M | ||
| Q1 25 | $288.6M | $96.0M | ||
| Q4 24 | $278.8M | $20.7M | ||
| Q3 24 | $267.8M | $69.4M | ||
| Q2 24 | $217.4M | $-8.4M | ||
| Q1 24 | $238.8M | $47.0M |
| Q4 25 | $116.7M | $60.6M | ||
| Q3 25 | $83.7M | $53.8M | ||
| Q2 25 | $113.3M | $-43.9M | ||
| Q1 25 | $125.5M | $59.0M | ||
| Q4 24 | $80.1M | $-10.3M | ||
| Q3 24 | $120.3M | $42.0M | ||
| Q2 24 | $60.5M | $-41.1M | ||
| Q1 24 | $99.4M | $-2.0M |
| Q4 25 | 7.6% | 4.1% | ||
| Q3 25 | 5.7% | 3.6% | ||
| Q2 25 | 7.8% | -2.9% | ||
| Q1 25 | 8.6% | 3.8% | ||
| Q4 24 | 5.7% | -0.7% | ||
| Q3 24 | 8.9% | 2.8% | ||
| Q2 24 | 4.6% | -2.7% | ||
| Q1 24 | 7.6% | -0.1% |
| Q4 25 | 14.8% | 2.0% | ||
| Q3 25 | 12.7% | 2.2% | ||
| Q2 25 | 10.8% | 1.9% | ||
| Q1 25 | 11.2% | 2.4% | ||
| Q4 24 | 14.1% | 2.1% | ||
| Q3 24 | 10.9% | 1.8% | ||
| Q2 24 | 12.1% | 2.1% | ||
| Q1 24 | 10.6% | 2.9% |
| Q4 25 | 2.37× | 9.66× | ||
| Q3 25 | 2.14× | 6.15× | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 2.31× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
WOOF
| Consumables | $731.5M | 50% |
| Supplies And Companion Animals | $478.1M | 33% |
| Services & Other | $254.8M | 17% |
